<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Daratumumab in Combination With Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma]]></title><description><![CDATA[<p dir="auto">Daratumumab in Combination With Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma<br />
This study is not yet open for participant recruitment.<br />
Verified June 2012 by Genmab</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448458/daratumumab-in-combination-with-bortezomib-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma</link><generator>RSS for Node</generator><lastBuildDate>Fri, 19 Jun 2026 11:17:58 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448458.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 15 Jun 2012 16:41:30 GMT</pubDate><ttl>60</ttl></channel></rss>